APA

Weiss G. J., Hidalgo M., Borad M. J., Laheru D., Tibes R., Ramanathan R. K., Blaydorn L., Jameson G., Jimeno A., Isaacs J. D., Scaburri A., Pacciarini M. A., Fiorentini F., Ciomei M. & Von Hoff D. D. (20130404). Phase I study of the safety, tolerability and pharmacokinetics of PHA-848125AC, a dual tropomyosin receptor kinase A and cyclin-dependent kinase inhibitor, in patients with advanced solid malignancies. : Investigational new drugs.

Chicago

Weiss Glen J, Hidalgo Manuel, Borad Mitesh J, Laheru Daniel, Tibes Raoul, Ramanathan Ramesh K, Blaydorn Lisa, Jameson Gayle, Jimeno Antonio, Isaacs Jeffrey D, Scaburri Angela, Pacciarini Maria Adele, Fiorentini Francesco, Ciomei Marina and Von Hoff Daniel D. 20130404. Phase I study of the safety, tolerability and pharmacokinetics of PHA-848125AC, a dual tropomyosin receptor kinase A and cyclin-dependent kinase inhibitor, in patients with advanced solid malignancies. : Investigational new drugs.

Harvard

Weiss G. J., Hidalgo M., Borad M. J., Laheru D., Tibes R., Ramanathan R. K., Blaydorn L., Jameson G., Jimeno A., Isaacs J. D., Scaburri A., Pacciarini M. A., Fiorentini F., Ciomei M. and Von Hoff D. D. (20130404). Phase I study of the safety, tolerability and pharmacokinetics of PHA-848125AC, a dual tropomyosin receptor kinase A and cyclin-dependent kinase inhibitor, in patients with advanced solid malignancies. : Investigational new drugs.

MLA

Weiss Glen J, Hidalgo Manuel, Borad Mitesh J, Laheru Daniel, Tibes Raoul, Ramanathan Ramesh K, Blaydorn Lisa, Jameson Gayle, Jimeno Antonio, Isaacs Jeffrey D, Scaburri Angela, Pacciarini Maria Adele, Fiorentini Francesco, Ciomei Marina and Von Hoff Daniel D. Phase I study of the safety, tolerability and pharmacokinetics of PHA-848125AC, a dual tropomyosin receptor kinase A and cyclin-dependent kinase inhibitor, in patients with advanced solid malignancies. : Investigational new drugs. 20130404.